Business ❯ Pharmaceuticals

Licensing Agreements

Patent Litigation Sanofi Oncology Cancer Drugs Cancer Treatment Market Strategy Arrowhead Pharmaceuticals Partnerships Collaborations Product Development Obesity Medications

Lilly Licenses MeiraGTx Eye Gene Therapy in Deal Worth Up to $475 Million

The agreement deepens Lilly’s push into ophthalmic gene medicines following its October move to buy Adverum Biotechnologies.

Novartis Licenses Arrowhead’s RNAi Parkinson’s Drug in Deal Worth Up to $2.2 Billion